BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 30369941)

  • 21. Molecular findings in patients for whole exome sequencing and mitochondrial genome assessment.
    Sun G; Huang W; Wang L; Wu J; Zhao G; Ren H; Liu L; Kong X
    Clin Chim Acta; 2024 Jun; 561():119774. PubMed ID: 38852791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exome sequencing in mostly consanguineous Arab families with neurologic disease provides a high potential molecular diagnosis rate.
    Charng WL; Karaca E; Coban Akdemir Z; Gambin T; Atik MM; Gu S; Posey JE; Jhangiani SN; Muzny DM; Doddapaneni H; Hu J; Boerwinkle E; Gibbs RA; Rosenfeld JA; Cui H; Xia F; Manickam K; Yang Y; Faqeih EA; Al Asmari A; Saleh MA; El-Hattab AW; Lupski JR
    BMC Med Genomics; 2016 Jul; 9(1):42. PubMed ID: 27435318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New MT-ND6 and NDUFA1 mutations in mitochondrial respiratory chain disorders.
    Uehara N; Mori M; Tokuzawa Y; Mizuno Y; Tamaru S; Kohda M; Moriyama Y; Nakachi Y; Matoba N; Sakai T; Yamazaki T; Harashima H; Murayama K; Hattori K; Hayashi J; Yamagata T; Fujita Y; Ito M; Tanaka M; Nibu K; Ohtake A; Okazaki Y
    Ann Clin Transl Neurol; 2014 May; 1(5):361-9. PubMed ID: 25356405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole exome sequencing diagnosis of inborn errors of metabolism and other disorders in United Arab Emirates.
    Al-Shamsi A; Hertecant JL; Souid AK; Al-Jasmi FA
    Orphanet J Rare Dis; 2016 Jul; 11(1):94. PubMed ID: 27391121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of next-generation sequencing technologies in diagnosis of Mendelian mitochondrial diseases and reflections on clinical spectrum.
    Kose M; Isik E; Aykut A; Durmaz A; Kose E; Ersoy M; Diniz G; Adebali O; Ünalp A; Yilmaz Ü; Karaoğlu P; Edizer S; Tekin HG; Özdemir TR; Atik T; Onay H; Özkınay F
    J Pediatr Endocrinol Metab; 2021 Apr; 34(4):417-430. PubMed ID: 33629572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-Exome Sequencing Uncovers Novel Causative Variants and Additional Findings in Three Patients Affected by Glycogen Storage Disease Type VI and Fanconi-Bickel Syndrome.
    Eghbali M; Fatemi KS; Salehpour S; Abiri M; Saei H; Talebi S; Olyaei NA; Yassaee VR; Modarressi MH
    Front Genet; 2020; 11():601566. PubMed ID: 33505429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-Küster-Hauser syndrome.
    Chen MJ; Wei SY; Yang WS; Wu TT; Li HY; Ho HN; Yang YS; Chen PL
    Hum Reprod; 2015 Jul; 30(7):1732-42. PubMed ID: 25924657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial dysfunction and autism: comprehensive genetic analyses of children with autism and mtDNA deletion.
    Varga NÁ; Pentelényi K; Balicza P; Gézsi A; Reményi V; Hársfalvi V; Bencsik R; Illés A; Prekop C; Molnár MJ
    Behav Brain Funct; 2018 Feb; 14(1):4. PubMed ID: 29458409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next generation molecular diagnosis of mitochondrial disorders.
    Wong LJ
    Mitochondrion; 2013 Jul; 13(4):379-87. PubMed ID: 23473862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted next-generation sequencing identifies pathogenic variants in familial congenital heart disease.
    Blue GM; Kirk EP; Giannoulatou E; Dunwoodie SL; Ho JW; Hilton DC; White SM; Sholler GF; Harvey RP; Winlaw DS
    J Am Coll Cardiol; 2014 Dec; 64(23):2498-506. PubMed ID: 25500235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted next generation sequencing with an extended gene panel does not impact variant detection in mitochondrial diseases.
    Plutino M; Chaussenot A; Rouzier C; Ait-El-Mkadem S; Fragaki K; Paquis-Flucklinger V; Bannwarth S
    BMC Med Genet; 2018 Apr; 19(1):57. PubMed ID: 29625556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caution in interpretation of disease causality for heterozygous loss-of-function variants in the MYH8 gene associated with autosomal dominant disorder.
    Dai Z; Whitt Z; Mighion LC; Pontoglio A; Bean LJH; Colombo R; Hegde M
    Eur J Med Genet; 2017 Jun; 60(6):312-316. PubMed ID: 28377322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic Diagnosis Using Whole Exome Sequencing in Common Variable Immunodeficiency.
    Maffucci P; Filion CA; Boisson B; Itan Y; Shang L; Casanova JL; Cunningham-Rundles C
    Front Immunol; 2016; 7():220. PubMed ID: 27379089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders: cohort study.
    Schon KR; Horvath R; Wei W; Calabrese C; Tucci A; Ibañez K; Ratnaike T; Pitceathly RDS; Bugiardini E; Quinlivan R; Hanna MG; Clement E; Ashton E; Sayer JA; Brennan P; Josifova D; Izatt L; Fratter C; Nesbitt V; Barrett T; McMullen DJ; Smith A; Deshpande C; Smithson SF; Festenstein R; Canham N; Caulfield M; Houlden H; Rahman S; Chinnery PF;
    BMJ; 2021 Nov; 375():e066288. PubMed ID: 34732400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of whole exome sequencing for the early diagnosis of pediatric-onset cerebellar atrophy associated with developmental delay in an inbred population.
    Megahed H; Nicouleau M; Barcia G; Medina-Cano D; Siquier-Pernet K; Bole-Feysot C; Parisot M; Masson C; Nitschké P; Rio M; Bahi-Buisson N; Desguerre I; Munnich A; Boddaert N; Colleaux L; Cantagrel V
    Orphanet J Rare Dis; 2016 May; 11(1):57. PubMed ID: 27146152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of Whole Exome Sequencing to Identify Causative Mutations in Familial Congenital Heart Disease.
    LaHaye S; Corsmeier D; Basu M; Bowman JL; Fitzgerald-Butt S; Zender G; Bosse K; McBride KL; White P; Garg V
    Circ Cardiovasc Genet; 2016 Aug; 9(4):320-9. PubMed ID: 27418595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosomal microarray and exome sequencing in unexplained early infantile epileptic encephalopathies in a highly consanguineous population.
    Turkdogan D; Turkyilmaz A; Sager G; Ozturk G; Unver O; Say M
    Int J Neurosci; 2023 Jul; 133(7):683-700. PubMed ID: 34380004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved diagnostic yield of neuromuscular disorders applying clinical exome sequencing in patients arising from a consanguineous population.
    Fattahi Z; Kalhor Z; Fadaee M; Vazehan R; Parsimehr E; Abolhassani A; Beheshtian M; Zamani G; Nafissi S; Nilipour Y; Akbari MR; Kahrizi K; Kariminejad A; Najmabadi H
    Clin Genet; 2017 Mar; 91(3):386-402. PubMed ID: 27234031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole exome sequencing is an alternative method in the diagnosis of mitochondrial DNA diseases.
    Sun C; Wu S; Chen R; Liu J; Wang J; Ma Y; Yuan Z; Li Y
    Mol Genet Genomic Med; 2022 Jun; 10(6):e1943. PubMed ID: 35388601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.